**Core Concept**
Secondary hyperparathyroidism is a condition characterized by an overproduction of parathyroid hormone (PTH) in response to a sustained decrease in serum calcium levels. This is often seen in conditions where there is a deficiency in vitamin D or an inability to absorb calcium, leading to hypocalcemia.

**Why the Correct Answer is Right**
The parathyroid glands increase PTH secretion in an attempt to maintain normal serum calcium levels. This is achieved by increasing calcium reabsorption in the kidneys, increasing calcium release from bone, and decreasing calcium excretion in the urine. The increased PTH levels also lead to decreased phosphate levels in the blood.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because vitamin D deficiency is a well-known cause of secondary hyperparathyroidism. Vitamin D plays a crucial role in calcium absorption from the gut, and its deficiency leads to decreased calcium levels, triggering the release of PTH.
**Option B:** This option is incorrect because chronic kidney disease (CKD) is a common cause of secondary hyperparathyroidism. CKD leads to a decrease in the production of active vitamin D and an increase in phosphate levels, which in turn leads to an increase in PTH levels.
**Option C:** This option is incorrect because osteomalacia is a condition characterized by softening of the bones due to vitamin D deficiency. It is often associated with secondary hyperparathyroidism.

**Clinical Pearl / High-Yield Fact**
Secondary hyperparathyroidism can lead to the development of brown tumors, which are osteoclastic lesions that occur in response to the increased PTH levels. These tumors are often seen in the jaw, pelvis, and long bones.

**Correct Answer: D. Osteoporosis**